KC-2983

PC3-PSMA

×
26365
Home » PC3-PSMA

Background of PC3-PSMA

PSMA, also known as FOLH1, is a type II transmembrane glycoprotein belonging to the M28 peptidase family, which is a glutamate-preferring carboxy-peptidase. PSMA is highly expressed in the prostate secretory-acinar epithelium, in some benign extraprostatic epithelial cells from breast, duodenum, and kidney tissues, and prostate cancer. In the prostate, the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer.

Specifications

Catalog NumberKC-2983
Cell Line NamePC3-PSMA
NCBI/UniProt Accession NumberNM_004476.2
Clone Number24#
Host Cell LinePC3 Cell Line
DescriptionStable PC3 cell line expressing exogenous human PSMA gene
QuantityOne vial of frozen cells (≥2×106 cells)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing MediumHam's F12K + 20% FBS + 10% DMSO
Propagation MediumHam's F12K + 10% FBS + 1μg/ml Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:2-1:4 every 2-3 days
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 35 hours
Mycoplasma StatusNegative
In Vivo ValidationYes

Cell Line Generation

PC3 human PSMA cell line was generated using a lentiviral vector expressing the human PSMA sequence.

Characterization

Figure1: Characterization of human PSMA overexpression in PC3 human PSMA stable clones using FACS.

Figure2: Characterization of human PSMA expression in PC3 cells using FACS.

Figure3: Characterization of PC3 human PSMA stable clone using PCR sequencing.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO2 incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:2-1:4 every 2-3 days upon reaching 70%-80% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the cell pellet in chilled freezing medium, ensuring a minimum cell density of 3×106 cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer. PMID: 34829977 PMCID: PMC8621856 DOI: 10.3390/ijms222212095.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.